Skip to content
OpenCapital
Get started

iBio IBIO Q4 2025 earnings

Reported February 10, 2026 · Before market open

EPS-$0.09Miss by $0.01
Revenue estimate$50.0K
EPS estimate-$0.08

Next report

Sep 4, 2026 (in a month)
Revenue estimate$33.3K
EPS estimate-$0.07

Versus estimates

Revenue

Q3 2025$100.0KBeat by $66.7KQ2 2025$200.0KBeat by $100.0KQ4 2024$200.0K

Diluted EPS

Q1 2026-$0.07Miss by $0.01
Q4 2025-$0.09Miss by $0.01
Q3 2025-$0.11Miss by $0.04Q2 2025-$0.31Beat by $0.08Q1 2025-$0.49Miss by $0.10Q4 2024-$0.48Miss by $0.03

Ask the moment iBio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did iBio report Q4 2025 earnings?
iBio (IBIO) reported Q4 2025 earnings on February 10, 2026 before market open.
What were iBio's Q4 2025 revenue and EPS?
iBio reported eps of $-0.09 for Q4 2025.
Did iBio beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.08 by $0.01.
How did iBio's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 81.3% from $-0.48.
Where can I find iBio's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001420720-26-000003) and the 10-Q periodic report (0001420720-26-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.